A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions

Genetically-engineered mouse models (GEMMs) lacking diseased-associated gene(s) globally or in a tissue-specific manner represent an attractive tool with which to assess the efficacy and toxicity of targeted pharmacological inhibitors. Stat3 and Stat5a/b transcription factors have been implicated in several pathophysiological conditions, and pharmacological inhibition of both transcription factors has been proposed to treat certain diseases, such as malignancies. To model combined inhibition of Stat3 and Stat5a/b we have developed a GEMM harboring a flox Stat3-Stat5a/b allele (Stat5/3loxP/loxP mice) and generated mice lacking Stat3 and Stat5a/b in hepatocytes (Stat5/3Δhep/Δhep). Stat5/3Δhep/Δhep mice exhibited a marked reduction of STAT3, STAT5A and STAT5B proteins in the liver and developed steatosis, a phenotype that resembles mice lacking Stat5a/b in hepatocytes. In addition, embryonic deletion of Stat3 and Stat5a/b (Stat5/3Δ/Δ mice) resulted in lethality, similar to Stat3Δ/Δ mice. This data illustrates that Stat5/3loxP/loxP mice are functional and can be used as a valuable tool to model the combined inhibition of Stat3 and Stat5a/b in tumorigenesis and other diseases.

• Publication year

  2019

• Venue

  Cancers

• Publication date

  2019-08-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3390/cancers11091226PMID 31443474PMCID 6770775
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication

  2019cited by this paper
• Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia

  2017cited by this paper
• Targeting JAK kinase in solid tumors: emerging opportunities and challenges

  2016cited by this paper
• Chromosomal Abnormalities in Embryonic and Somatic Stem Cells

  2015cited by this paper
• The JAK-STAT pathway: impact on human disease and therapeutic intervention.

  2015cited by this paper
• Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice.

  2015cited by this paper
• Correction: Stat3 Activation Is Responsible for IL-6–Dependent T Cell Proliferation through Preventing Apoptosis: Generation and Characterization of T Cell–Specific Stat3-Deficient Mice

  2015cited by this paper
• Genetically Engineered Mouse Models for Drug Development and Preclinical Trials

  2014cited by this paper
• Variation in Genome-Wide Levels of Meiotic Recombination Is Established at the Onset of Prophase in Mammalian Males

  2014cited by this paper
• Drug Resistance in Cancer: An Overview

  2014cited by this paper
• Neither signal transducer and activator of transcription 3 (STAT3) or STAT5 signaling pathways are required for leptin's effects on fertility in mice.

  2013cited by this paper
• STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.

  2013cited by this paper
• Gene targeting and site-specific recombination in mouse ES cells.

  2013cited by this paper
• Transposon-mediated BAC transgenesis in human ES cells

  2012cited by this paper
• Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis.

  2010cited by this paper
• Disruption of the growth hormone—Signal transducer and activator of transcription 5—Insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis

  2010cited by this paper
• Targeted transgenesis at the HPRT locus: an efficient strategy to achieve tightly controlled in vivo conditional expression with the tet system.

  2009cited by this paper
• Agouti C57BL/6N embryonic stem cells for mouse genetic resources

  2009cited by this paper
• Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-β and STAT3 activation

  2009cited by this paper
• Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity.

  2008cited by this paper
• Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration

  2007influential reference
• JAK-STAT Signaling: From Interferons to Cytokines*

  2007cited by this paper
• An improved recombineering approach by adding RecA to lambda Red recombination.

  2006cited by this paper
• An improved recombineering approach by adding RecA to λ Red recombination

  2006cited by this paper
• The JAK/STAT signaling pathway

  2004cited by this paper
• Inactivation of Stat5 in Mouse Mammary Epithelium during Pregnancy Reveals Distinct Functions in Cell Proliferation, Survival, and Differentiation

  2004cited by this paper
• Engineering the mouse genome with bacterial artificial chromosomes to create multipurpose alleles

  2003cited by this paper
• STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: A critical role of STAT3 in innate immunity

  2003cited by this paper
• Site-specific gene targeting in mouse embryonic stem cells with intact bacterial artificial chromosomes

  2003cited by this paper
• Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age

  2003cited by this paper
• STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation.

  2002cited by this paper
• A highly specific and sensitive fluorescence in situ hybridization assay for the detection of t(4;11)(q21;q23) and concurrent submicroscopic deletions in acute leukaemias

  2002cited by this paper
• Codon‐improved Cre recombinase (iCre) expression in the mouse

  2002cited by this paper
• Conditional mutagenesis of CamKIV

  2002cited by this paper
• Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver.

  2001cited by this paper
• Essential Role of STAT3 in the Control of the Acute-Phase Response as Revealed by Inducible Gene Activation in the Liver

  2001cited by this paper
• Genotype to phenotype: challenges and opportunities

  2000cited by this paper
• Hepatocyte‐specific expression of Cre recombinase

  2000cited by this paper
• Engineering Mouse Chromosomes with Cre-loxP: Range, Efficiency, and Somatic Applications

  2000cited by this paper
• Rapid modification of bacterial artificial chromosomes by ET-recombination.

  1999cited by this paper
• Inducible Gene Knockouts in the Small Intestinal and Colonic Epithelium*

  1999cited by this paper
• Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice.

  1998cited by this paper
• Analysis of Fgf8 gene function in vertebrate development.

  1997cited by this paper
• Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.

  1997cited by this paper
• Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.

  1996cited by this paper
• A new mouse embryonic stem cell line with good germ line contribution and gene targeting frequency.

  1992cited by this paper

• STAT-independent functions of Janus kinases 1 and 2 are obligatory for the postnatal development of mammary epithelial ducts.

  2025cites this paper
• Evolutionary, comparative, and functional analyses of STATs and regulation of the JAK-STAT pathway in lumpfish upon bacterial and poly(I:C) exposure

  2023cites this paper
• Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways

  2022cites this paper
• JAK-STAT Signalling Pathway in Cancer

  2020cites this paper